Roivant Sciences Noncash Other decreased by 33775.0% to -$14.82M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 647.6%, from -$1.98M to -$14.82M.
Generally neutral, but large or recurring values may warrant investigation into accounting adjustments.
A catch-all category for miscellaneous non-cash adjustments that do not fit into standard operating, investing, or finan...
Standard line item in cash flow reconciliations; usually immaterial.
other_noncash_other| Q3 '21 | Q4 '21 | Q1 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q1 '25 | Q2 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $258.00K | $1.20M | $691.00K | $6.37M | -$33.00K | $66.00K | $268.00K | -$742.00K | $113.00K | -$1.98M | $44.00K | -$14.82M |
| QoQ Change | — | +364.3% | -42.3% | +822.1% | -100.5% | +300.0% | +306.1% | -376.9% | +115.2% | <-999% | +102.2% | <-999% |
| YoY Change | — | — | — | >999% | -104.8% | — | -95.8% | — | +442.4% | <-999% | -61.1% | -647.6% |